LOS ANGELES--(BUSINESS WIRE)--Today, AIDS Healthcare Foundation (AHF) praised drug giant Johnson & Johnson (J&J) for offering discounts on its AIDS drugs for cash-strapped state AIDS Drug Assistance Programs (ADAPs). It was announced today that an enhanced agreement between the ADAP Crisis Task Force (ACTF) and Janssen Therapeutics, a subsidiary of Johnson & Johnson had been reach to provide additional discounts and rebates to AIDS Drug Assistance Programs (ADAPs) on all of its AIDS medications. ADAPs, a network of federal and state funded programs that provide life-saving HIV treatments to low income, uninsured, and underinsured individuals living with HIV/AIDS nationwide, are facing a severe financial crisis that has left as many as 10,000 people with AIDS without access to treatment.
